Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajan Datar

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
JCO Precision Oncology|January 7, 2022
Reply to S. Cavalieri et alSewanti Limaye, Prashant Kumar, Rajan Datar, et al.
Journal of Personalized Medicine|July 10, 2019
Adaptive, Iterative, Long-Term Personalized Therapy Management in a Case of Stage IV Refractory NSCLCAnantbhushan Ranade, Darshana Patil, Amit Bhatt, et al.
Frontiers in Oncology|January 9, 2023
Multi-analyte liquid biopsies for molecular pathway guided personalized treatment selection in advanced refractory cancers: A clinical utility pilot studyDarshana Patil, Dadasaheb Akolkar, Rajnish Nagarkar, et al.
International Journal of Cancer|December 26, 2023
Profiling of circulating glial cells for accurate blood-based diagnosis of glial malignanciesKevin O'Neill, Nelofer Syed, Timothy Crook, et al.
JCO Precision Oncology|May 26, 2021
Excellent Response With Alpelisib and Bicalutamide for Advanced Salivary Duct Carcinoma With PIK3CA Mutation and High Androgen Receptor Expression-A Case ReportHardik Sheth, Prashant Kumar, Aditya Shreenivas, et al.
Oncotarget|December 1, 2022
Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancerSewanti Limaye, Prashant Kumar, Ramya Pragya, et al.
Oncotarget|November 27, 2020
A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancerSewanti Limaye, Prashant Kumar, Ramya Pragya, et al.
Molecular Oncology|January 26, 2026
Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancerJanani Sambath, Irene A George, Srikanth S Manda, et al.
Oncotarget|November 7, 2022
Addendum: Liquid biopsy and multi-analyte testing guided treatment of <i>HER2</i> positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapyRajnish Nagarkar, Darshana Patil, Sewanti Limaye, et al.
Clinical Case Reports|November 12, 2021
Response to pazopanib-based combination regimen in a case of FGFR3 amplified gastric adenocarcinomaSewanti Limaye, Darshana Patil, Dadasaheb Akolkar, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
JCO Precision Oncology|January 7, 2022
Reply to S. Cavalieri et alSewanti Limaye, Prashant Kumar, Rajan Datar, et al.
Journal of Personalized Medicine|July 10, 2019
Adaptive, Iterative, Long-Term Personalized Therapy Management in a Case of Stage IV Refractory NSCLCAnantbhushan Ranade, Darshana Patil, Amit Bhatt, et al.
Frontiers in Oncology|January 9, 2023
Multi-analyte liquid biopsies for molecular pathway guided personalized treatment selection in advanced refractory cancers: A clinical utility pilot studyDarshana Patil, Dadasaheb Akolkar, Rajnish Nagarkar, et al.
International Journal of Cancer|December 26, 2023
Profiling of circulating glial cells for accurate blood-based diagnosis of glial malignanciesKevin O'Neill, Nelofer Syed, Timothy Crook, et al.
JCO Precision Oncology|May 26, 2021
Excellent Response With Alpelisib and Bicalutamide for Advanced Salivary Duct Carcinoma With PIK3CA Mutation and High Androgen Receptor Expression-A Case ReportHardik Sheth, Prashant Kumar, Aditya Shreenivas, et al.
Oncotarget|December 1, 2022
Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancerSewanti Limaye, Prashant Kumar, Ramya Pragya, et al.
Oncotarget|November 27, 2020
A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancerSewanti Limaye, Prashant Kumar, Ramya Pragya, et al.
Molecular Oncology|January 26, 2026
Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancerJanani Sambath, Irene A George, Srikanth S Manda, et al.
Oncotarget|November 7, 2022
Addendum: Liquid biopsy and multi-analyte testing guided treatment of <i>HER2</i> positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapyRajnish Nagarkar, Darshana Patil, Sewanti Limaye, et al.
Clinical Case Reports|November 12, 2021
Response to pazopanib-based combination regimen in a case of FGFR3 amplified gastric adenocarcinomaSewanti Limaye, Darshana Patil, Dadasaheb Akolkar, et al.
Pageof 3